CAR T cells effectively targeted MUC1, a TAA closely related to tumour progression and therapeutic response, leading to durable and specific immune cytotoxicity in MUC1+ organoids but not MUC1− organoids.138. This evidence concerns the gene MUC1 and neoplasm.